The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations

被引:338
作者
Hall, RI
Smith, MS
Rocker, G
机构
[1] DALHOUSIE UNIV, DEPT ANAESTHESIA, HALIFAX, NS, CANADA
[2] DALHOUSIE UNIV, DEPT MED, HALIFAX, NS, CANADA
关键词
D O I
10.1097/00000539-199710000-00011
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:766 / 782
页数:17
相关论文
共 161 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[3]   HALOTHANE MORPHINE COMPARED WITH HIGH-DOSE SUFENTANIL FOR ANESTHESIA AND POSTOPERATIVE ANALGESIA IN NEONATAL CARDIAC-SURGERY [J].
ANAND, KJS ;
HICKEY, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) :1-9
[4]  
Andersen L W, 1989, J Cardiothorac Anesth, V3, P544, DOI 10.1016/0888-6296(89)90150-6
[5]   ASSOCIATION BETWEEN GASTRIC INTRAMUCOSAL PH AND SPLANCHNIC ENDOTOXIN, ANTIBODY TO ENDOTOXIN, AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS [J].
ANDERSEN, LW ;
LANDOW, L ;
BAEK, L ;
JANSEN, E ;
BAKER, S .
CRITICAL CARE MEDICINE, 1993, 21 (02) :210-217
[6]  
ANDERSEN LW, 1987, J THORAC CARDIOV SUR, V93, P115
[7]  
Ashraf S, 1997, ANN THORAC SURG, V63, P68
[8]   INHIBITION OF ALFENTANIL METABOLISM BY ERYTHROMYCIN [J].
BARTKOWSKI, RR ;
GOLDBERG, ME ;
LARIJANI, GE ;
BOERNER, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) :99-102
[9]   NEW ASPECTS CONCERNING THE REGULATION OF THE POSTOPERATIVE ACUTE-PHASE REACTION DURING CARDIAC-SURGERY [J].
BERGER, D ;
BOLKE, E ;
HUEGEL, H ;
SEIDELMANN, M ;
HANNEKUM, A ;
BEGER, HG .
CLINICA CHIMICA ACTA, 1995, 239 (02) :121-130
[10]  
BLICK M, 1987, CANCER RES, V47, P2986